Denali Therapeutics
DNLI
DNLI
210 hedge funds and large institutions have $6.31B invested in Denali Therapeutics in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 81 increasing their positions, 59 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 216 → 210 (-6)
13% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 39
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
210
Holding in Top 10
4
Calls
$30M
Puts
$7.7M
Top Buyers
| 1 | +$169M | |
| 2 | +$42.9M | |
| 3 | +$37M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$28M |
| 5 |
State Street
Boston,
Massachusetts
|
+$23.8M |
Top Sellers
| 1 | -$145M | |
| 2 | -$90.6M | |
| 3 | -$41M | |
| 4 |
Two Sigma Investments
New York
|
-$21.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$20.6M |